Search results for: 'medgen and acquisition deaco and alliance of 221b'
- Did you mean
 - merger and acquisition deal and alliance of 2016
 
- Related search terms
 - Acquisition Terms and Agreements in Pharma
 - acquisition texas and agreements in pharma
 - acquisitions terms and agreements in pharma
 - acquisitions term and agreements in pharma
 - 221b data alliance review
 
- 
                
                    
                    Infectious Vaccine Collaboration and Licensing Deals 2016-2025May 2025$3,995.00Infectious Vaccine Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2025
Learn More - 
                
                    
                    Gene Therapy Collaboration and Licensing Deals 2016-2025May 2025$3,995.00Gene Therapy Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2025
Learn More - 
                
                    
                    Genomic Collaboration and Licensing Deals 2018-2025May 2025$3,995.00Genomics Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2018 to 2025
Learn More - 
                
                    
                    Discovery Stage Partnering Terms and Agreements in Pharmaceuticals and Biotechnology 2020-2025August 2025$4,995.00The Discovery Stage Partnering Terms and Agreements in Pharma and Biotech (2020-2025) report offers in-depth insights and exclusive access to discovery-stage partnering agreements signed by the world’s leading biopharma companies, providing a detailed analysis of deal structures, financial terms and strategic collaborations.
Learn More - 
                
                    
                    Vaccine Collaboration and Licensing Deals 2016-2025May 2025$3,995.00Vaccine Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2025
Learn More - 
                
                    
                    Autoimmune Collaboration and Licensing Deals 2016-2025October 2025$3,995.00Autoimmune Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2025
Learn More - 
                
                    
                    Regenerative Medicine Collaboration and Licensing Deals 2019-2025May 2025$3,995.00Regenerative Medicine Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2019 to 2025
Learn More - 
                
                    
                    Collaboration Deals in Biotechnology 2020-2025September 2025$4,995.00Collaboration Deals in Biotechnology | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2020 to 2025
Learn More - 
                
                    
                    Global Animal Health Partnering Terms and Agreements 2017 to 2024October 2024$3,995.00Provides comprehensive understanding and unprecedented access to the animal health agreements entered into by the world's leading biopharma companies.
Learn More - 
                
                    
                    Biomarker Collaboration and Licensing Deals 2016-2025May 2025$3,995.00Biomarker Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2025
Learn More 
